Mackay Shields LLC’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Mackay Shields LLC’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-19,300	Closed	-$2.63M	–	1648
2020 Q3	$2.63M	Buy	19,300 +9,400	+95%	+$999K	0.02%	674
2020 Q2	$956K	Buy	+9,900	New	+$826K	0.01%	1033

Mackay Shields LLC's MYOK Position: Q4 2020 in Review

Mackay Shields LLC sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 19,300 shares — an estimated $2.63M sold.

Mackay Shields LLC first reported a position in MYOK in Q2 2020 and held it in 2 quarters. The position peaked at $2.63M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Mackay Shields LLC reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Mackay Shields LLC sold 19,300 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $2.63M.
Mackay Shields LLC first reported a position in MyoKardia, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
Mackay Shields LLC's MyoKardia, Inc. Common Stock position peaked at $2.63M in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Mackay Shields LLC's 13F filing for Q4 2020, filed 16 Feb 2021.